EIF4E and hepatocellular carcinoma: Sorafenib-induced SGs in HCC contain canonical SGs markers including FMRP, FXR1, G3BP1 (Fig. 1), eIF4E and eIF4GI (Fig. S3A), as well as poly(A)+ mRNA (Fig. S4).